Clinical Trials
4 trialsNCT04540588 2025-12-02
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
Alpha Tau Medical LTD.
Phase NA Completed
NCT03602079 2023-08-03
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
Phase 1/2 Completed
NCT03239834 2021-08-12
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Vigilant Biosciences, Inc.
Completed
NCT00050388 2008-06-24
Phase II Trial of Allovectin-7® for Head and Neck Cancer
Vical
Phase 3 Completed